Skip to content
Loop Biz – Lifestyle
Author:
Attovia Therapeutics, Inc.
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
September 28, 2026
Attovia Therapeutics to Participate in Upcoming Investor Conferences
September 3, 2026
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
September 2, 2026
Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 6, 2026
Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering
August 4, 2026
Attovia Therapeutics Appoints John W. Smither to Board of Directors
July 15, 2026